Section 325.9082. Reportable information.

Rule  2.  (1)  Reportable  information  pertains  to  the  analysis  of  blood  samples submitted to clinical laboratories and the results from portable blood lead analyzers.

(2)      Upon    initiating a request  for  blood lead  analysis,  the physician/provider or user ordering the blood lead analysis shall collect the following information:

(a) All of the following information with respect to the individual tested:

(i)   Name.

(ii)   Sex

(iii)   The individual’s ethnicity including either of the following:

(a)   Hispanic or Latino/Latina.

(b)   Not Hispanic of Latino/Latina.

(iv)   The individual’s race, noting the following:

(a)   American Indian or Alaska Native.

(b)   Asian.

(c)   Black or African American.

(d)  Native Hawaiian or Other Pacific Islander.

(e)   White or Caucasian.

(v)   Birthdate.

(vi)   Address, including county, and, to the extent available, whether the residence or property is owned or rented.

(vii)   Telephone number.

(viii)   Social security number and Medicaid number, if applicable.

(ix)   If the individual is a minor, the name of a parent or guardian.

(x)   If the individual is an adult, the name of his or her employer.

(xi)    A secondary contact for the individual tested or, if the individual is a minor, a secondary contact for the individual’s parent or guardian, including, to the extent available, name and phone number of the secondary contact.

(b)   The date of the sample collection.

(c)   The type of sample (capillary or venous).

(d)    The  physician’s/provider’s  or   user’s  name,  name  of  practice  (if  applicable), telephone number, fax number, email address, and mailing address.

(3)   The information collected in subrule (2) of this rule shall be submitted with the sample for analysis to a clinical laboratory that performs blood lead analysis or a user of a portable blood lead analyzer.

(4)   Upon receipt of the blood sample for lead analysis, the clinical laboratory or user of a portable blood lead analyzer shall collect the following additional information:

(a)   The name, address, and phone number of the laboratory or testing entity.

(b)   The date of analysis.

(c)   The specimen number.

(d)  The results of the blood lead analysis in micrograms of lead per deciliter of whole blood rounded to the nearest whole number.

History: 1997 AACS; 2015 AACS.